Peer reviewed publication supports intravenous Vitamin C for cancer patients

Current article ratings:
Patients / public:5 (2 votes)healthcare Prof:
The clinic Riordan announced publication in the journal of translational medicine results of a collaboration between oncologists, alternative medicine practitioners and basic researchers, a new use of intravenous Vitamin C for the treatment of cancer suggests.

The justification is provided, intravenously, but not oral vitamin C of issues in cancer patients can be wasting (cachexia), immune suppression, and improving the quality of life. 246 References, the paper citing existing knowledge on the use of intravenous Vitamin C for numerous medical conditions synthesized and searches reassessment of the place intravenous vitamin c in the context of the conventional oncology practice.

"Currently there is a large gap in the way, as intravenous Vitamin C will appear," said Thomas Ichim, Member of the Board of the Riordan clinic and first author of the publication. "On the one hand you have alternative medicine practitioners, who have been very interesting results in practical treatment of cancer patients that but not explain any molecular justification for its use or potential impact." On the other hand you have a large amount of scientific literature support possible importance of this approach in cancer. "This paper is an important step towards closing the gap."

In the past the use was considered controversial by vitamin C in the treatment of cancer because some studies have claimed life of cancer patients, very good results in expanding while other studies have not seen any effects. The discrepancy seems to be seeing positive studies effects use intravenous Vitamin C, while the failed studies oral vitamin C. declared scientists used in the clinic Riordan who publish first, and patented, that oral intravenous, but not vitamin C, kill significant concentration in the blood to selective tumor cells can achieve.

"We are proud to be a such multidisciplinary cooperation as part of this team including scientists/doctors from University of Western Ontario, Canada, Torrey Pines Research Institute, the University of Puerto Rico, University of Connecticut, University of Nebraska Medical Center had HabenUniversität of Latvia", Lawson Health Research Institute, and Loma Linda University, "said Brian Riordan, CEO of Riordan clinic."The Riordan clinic intravenous Vitamin C for decades; my personal mission uses the input from colleagues in the conventional Oncology is looking to find out how we can generate together best treatments for our patients. "This paper is a small step in what we expect will be many successful cooperation with our friends in conventional oncological practice." Funding for the publication was by Allan p. Markin pure North s ' Energy Foundation provided.

Source: Bio-Communications Research Institute